From 2018 to 2022, a total of 58 patients with unilateral orbital floor fractures were surgically treated in the Department of Maxillofacial Surgery, Clinic of Dental Medicine in Niš. This research was retrospective. The study adhered to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the Clinic for Dentistry in Niš (20/7-2018-3EO). Each patient signed a document of informed consent, which allowed the data from their medical records to be used in the preparation of a scientific article and stated that their identity would be anonymous. Those patients were followed up for at least 6 months. A titanium implant was used in 31 patients, and PDLLA (Resorb X, KLS Martin, Tuttlingen, Germany) implant in 27 patients.
The exclusion criteria were as follows: (1) bilateral orbital floor fractures, (2) ophthalmopathy associated with thyroid gland diseases, and (3) orbital tumors, since they can all cause increased orbital volume and measurement errors.
The exclusion criteria were as follows: (1) bilateral orbital floor fractures, (2) ophthalmopathy associated with thyroid gland diseases, and (3) orbital tumors, since they can all cause increased orbital volume and measurement errors.
